Plasma cortisol and beta-endorphin concentrations in trained and over-trained standardbred racehorses

The effects of training and over-training on plasma cortisol and beta-endorphin (betaEP) concentrations at rest and after standardised exercise tests and the cortisol responses to adrenocorticotropin (ACTH) administration were investigated in standardbred horses. Twelve horses were divided randomly into control and over-trained (OT) groups after 17 weeks slow- and moderate-intensity treadmill training. The standardised treadmill exercise test consisted of 2 min at velocities corresponding to 30, 50, 70 and 100% of maximum O2 consumption. Over-training, defined as a significant decrease in body weight and treadmill run-time-to-fatigue in an incremental velocity test, occurred in the OT group after 32 weeks of training exercise. Peak cortisol concentrations after exercise decreased significantly in the OT group from 320+/-15.6 at week 8 to 245+/-17.0 nmol l(-1) at week 32, and mean cortisol concentrations over a 120-min period after exercise decreased from 258+/-11.7 to 192+/-16.6 nmol l(-1) (P<0.05). Mean and total cortisol and betaEP concentrations in resting horses were not significantly different after over-training. Peak cortisol concentrations after adrenocorticotropin (ACTH) administration were not significantly different in the over-trained group. Dysfunction of the hypothalamo-pituitary-adrenocortical axis occurs in over-trained horses, but this adaptation is not associated with a change in the adrenocortical responsiveness to ACTH.

Sonographic observations of the peripheral vasculature of the equine thoracic limb

Investigations of the equine peripheral vascular system have been constrained by the lack of a non-invasive method of examining the arteries and veins of the limbs of the conscious horse. Precise correlations were established between the gross anatomical features of the peripheral vessels and their B-mode sonographic appearance in each thoracic limb of 35 horses. A sonographic imaging protocol was established. Additional Doppler sonographic recordings defined the arterial waveforms and demonstrated that blood flow to the foot could be evaluated in the lateral proper digital artery, distal to the level of the coronary band. Valves (with 2-4 cusps) were identified in the lumina of the medial and lateral palmar common digital veins and those of the medial and lateral palmar proper digital veins. Spontaneous echo contrast, a smoke-like haze of echoic blood, was seen in the lateral and medial palmar common digital veins, the distal deep palmar venous arch and communicating branches, and the palmar proper digital veins, and occasionally seen in the distal deep palmar arterial arch and distal proper palmar digital arteries. The value of duplex sonography (B-mode and Doppler) for anatomical and physiological studies of the peripheral vasculature of the horse was clearly established. Such data could be applied to the investigation of diseases affecting the peripheral circulation.

Effects of muscle glycogen depletion on some metabolic and physiological responses to submaximal treadmill exercise

The aim of this study was to investigate the effects of reduced muscle glycogen concentration on some physiological and metabolic responses during moderate intensity treadmill exercise in horses. Six Thoroughbred geldings were randomly allocated to 2 treatments (protocols A and B) or control in a 3 x 3 replicated Latin square design. In protocol A, horses performed low intensity exercise while horses in protocol B performed short bursts of high intensity exercise. Protocol A was designed to induce glycogen depletion mainly of slow twitch muscle fibers while protocol B aimed to deplete mainly fast twitch muscle fibers. Horses in the control group did not undergo exercise prior to the exercise test. Five hours after glycogen depletion, horses performed treadmill exercise at 60% VO2max at a treadmill slope of 10% until fatigue (20-30 min). The induced glycogen depletion prior to exercise had no significant effect on plasma glucose, insulin, or lactate concentrations during the exercise test, and there was no effect on glycogen utilization rate, although respiratory exchange ratios were lower in the glycogen-depleted groups. The VO2, heart rate and central blood temperature did not vary significantly between the protocols A and B and control throughout the exercise test. It was concluded that 20-30% depletion of glycogen concentration in the middle gluteal muscle resulted in a shift towards fat metabolism, but does not significantly affect heart rate, oxygen uptake, or concentrations of plasma glucose and lactate during moderate intensity exercise.

Haematological and biochemical responses to training and overtraining

We sought a physiological marker of overtraining in horses, using commonly practised field and laboratory tests to allow early prediction and treatment of the syndrome. Thirteen Standardbred horses were trained as follows: phase 1 (endurance, 7 weeks), phase 2 (high intensity, 9 weeks) and phase 3 (overload, 18 weeks). In phase 3 the horses were divided into 2 groups: overload training (OLT) and control (C). The OLT group exercised at greater intensities, frequencies and durations than the C group. Overtraining occurred after 31 weeks and was defined as a significant decrease in treadmill run time to fatigue (RT) in response to a standardised exercise test (SET). Variables measured included: feed intake, bodyweight (BWT), resting haematology and plasma biochemistry and treadmill SETs to measure RT. The OLT group had a decrease in BWT after week 28 (P < 0.05) without a reduction in feed intake and a reduction in RT during the SET after 31 weeks. Signs persisted after 2 weeks of a reduced training load confirming overtraining. Haematology and biochemistry failed to detect any markers of overtraining. Although no physiological markers of overtraining were identified, empirical observations revealed that the behaviour of horses in the OLT group was different from those in the C group during the period of overtraining. This study reflects that a model of overtraining has been developed based on measurement of a reduction in performance; however, there were no consistent changes in haematology or serum biochemical values in association with the decrement in performance capacity.

Effects of low- and moderate-intensity training on metabolic responses to exercise in thoroughbreds

This experiment was undertaken to determine whether there were differences in cardiorespiratory, haematological and muscular responses in horses trained at either low or moderate intensities. Ten Thoroughbred horses previously rested in paddocks for 4 months were trained 5 days/week for 9 weeks. Horses were allocated randomly into fast or slow groups and exercised the same distance each day. Training distances were 1600 m in Weeks 0 and 1 up to 4000 m in Week 9. The fast group were trained at an intensity inducing a post training blood lactate of 4-8 mmol/l. This intensity was determined for each horse each week. The slow group trained at half the speed of the fast group (blood lactate < 2 mmol/l). Horses performed a standardised exercise test prior to (Week 0) and on Weeks 1, 2, 3, 4, 7 and 9 of training. HR, VO2, VCO2 and blood lactate concentration were recorded during the last 15 s of each step. Blood samples were collected at the end of each test for determination of red cell and plasma volume. Muscle biopsies were collected from the middle gluteal muscle before training and after 4 and 9 weeks training. Training intensity had few effects on the majority of variables measured and results for both groups are combined unless otherwise stated. Bodyweight was unaffected by training. Economy of locomotion decreased from 12.0 +/- 0.4 ml/kg bwt/m prior to training to 13.8 +/- 0.6 ml/kg bwt/m at the end of training in the fast group. Run time to fatigue was not affected by training intensity. VO2max increased from 120.3 +/- 4.8 to 144.7 +/- 3.5 ml/kg bwt/min with a significant correlation between run time and VO2max. Peak HR was 221.4 +/- 2.5 beats/min prior to training and 226.5 +/- 1.7 beats/min after the first 4 weeks of training. V200 and VLa4 increased in response to training. Similarly, VLa4 increased from 7.0 +/- 0.5 to 9.2 +/- 0.2 m/s with VLa4 correlated to VO2max. Plasma volume decreased from 29.1 +/- 1.7 to 25.8 +/- 0.9 l during the last 3 weeks of training. Blood volume, red cell volume and/or red cell volume/kg were unaffected by intensity or duration of training. The activity of CS in muscle increased in the first 5 weeks of training whereas HAD activity was not affected by intensity or duration of training.

Blood gas changes during incremental and sprint exercise

We investigated and compared arterial blood gas and ventilatory changes during rapid acceleration sprint and during incremental treadmill exercise. Seven clinically normal racehorses completed standardised incremental exercise tests and rapid acceleration tests at speeds calculated to elicit 115% VO2max. Arterial oxygen tension decreased (P < 0.001) between 15 s (mean +/- s.d. 103.8 +/- 14.3 mmHg) and 30 s (85.0 +/- 7.7 mmHg) after the onset of rapid acceleration exercise, but did not change significantly during the remainder of the sprint. This was accompanied by an increase in PaCO2 of 5.9 mmHg (P < 0.05). Despite reductions in SaO2 during exercise, CaO2 did not change due to increases in haemoglobin concentration. Heart rate increased rapidly (P < 0.001) during the first 15 s of exercise and thereafter remained constant. The mean maximum speed during the incremental test (11.4 +/- 0.5 m/s) was not significantly different to the speed calculated to elicit 115% VO2max during the sprint test (12.2 +/- 0.8 m/s). The mean peak HR and Hb during the sprint test were significantly less than during the incremental test. However, there were no significant differences in the maximum or minimum values achieved for other variables. We conclude that rapid acceleration exercise is accompanied by rapid changes in blood gas variables, reaching steady state within 45 s. Blood gas responses during the simpler incremental test describe maximal changes during high-intensity sprint exercise.

Maximal exercise transiently disrupts hormonal secretory patterns in standardbred geldings

Basal concentrations of cortisol (CORT), beta-endorphin (beta EP), growth hormone (GH) and testosterone (T) and their disruption during 32 h of recovery after treadmill exercise were investigated in 4 geldings. Blood samples were collected from resting horses every 20 min between 0600-1000 and 1500-1900 h, and hourly between 1000-1500 h on 3 consecutive days. Treadmill exercise tests comprising 2 min intervals at 30, 50, and 70% VO2max then to fatigue at 100% VO2max were conducted between 1020-1130 h on Day 2. Blood was collected before, during and 15, 30, 60 and 90 min after exercise. Mean (Cav), peak (Cmax) and total (i.e. integrated) (Ctot) concentrations were calculated for CORT, beta EP and GH during the 20 min sampling sessions, and for CORT, beta EP, GH and T between 1000-1300 h on Days 1-3 (incorporating the samples during exercise on Day 2) and 1300-1900 h on Days 1-3. Cav, Cmax and Ctot for CORT, beta EP, GH and T were greater during exercise and recovery than in the same period on Day 1. Cav and Ctot values for plasma T during the 1300-1900 h period were significantly elevated on Day 2 and compared to Day 1 (P < 0.05), but there were no differences between Days 1 and 3 values for these variables. We concluded that plasma T concentration increases in response to maximal exercise in geldings, as does plasma CORT, beta EP and GH. Furthermore, maximal exercise disrupts basal plasma concentrations of CORT, beta EP and GH for up to 24 h and T for 26-32 h post exercise in geldings, therefore reflecting the minimum recovery periods required before evaluating normal, resting levels of these hormones in horses undergoing training.

Progression to AIDS: the effects of stress, depressive symptoms, and social support

OBJECTIVE

We examined the effects of stress, depressive symptoms, and social support on the progression of HIV infection.

METHODS

Eighty-two HIV-infected gay men without symptoms or AIDS at baseline were followed up every 6 months for up to 5.5 years. Men were recruited from rural and urban areas in North Carolina as part of the Coping in Health and Illness Project. Disease progression was defined using criteria for AIDS (CD4+ lymphocyte count of <200/microl and/or an AIDS-indicator condition).

RESULTS

We used Cox regression models with time-dependent covariates, adjusting for age, education, race, baseline CD4+ count, tobacco use, and number of antiretroviral medications. Faster progression to AIDS was associated with more cumulative stressful life events (p = .002), more cumulative depressive symptoms (p = .008), and less cumulative social support (p = .0002). When all three variables were analyzed together, stress and social support remained significant in the model. At 5.5 years, the probability of getting AIDS was about two to three times as high among those above the median on stress or below the median on social support compared with those below the median on stress or above the median on support, respectively.

CONCLUSIONS

These data are among the first to demonstrate that more stress and less social support may accelerate the course of HIV disease progression. Additional study will be necessary to elucidate the mechanisms that underlie these relationships and to determine whether interventions that address stress and social support can alter the course of HIV infection.

An antigen receptor (NCCRP-1) on nonspecific cytotoxic cells is a phosphoprotein associated with the JAK-STAT activation pathway

The antigen receptor (nonspecific cytotoxic cell receptor protein-1/NCCRP-1) on nonspecific cytotoxic cells (NCC) is a 32-kDa predicted Type III membrane protein. The N-terminal cytoplasmic portion of this receptor contains full length and truncated BOX-1 motifs. These motifs are also found on cytokine, erythropoietin and growth hormone receptors and provide docking sites for JAK kinases. In the present study, we investigated a relationship between NCCRP-1 and JAK2 kinase binding. A possible association with further downstream STAT activation was suggested. NCCRP-1 was phosphorylated on C-terminal domain serine residues. To examine the possibility that NCCRP-1 was associated with JAK kinase(s), NCC were purified and lysates were probed by Westen blotting (WB) for the presence of JAK2 kinase. Unlike their mammalian counterparts, NCC JAK2 kinase existed as a 90-95-kDa primary and a 35-40-kDa secondary breakdown product. Both mol wt. forms were significantly smaller than those reported for human JAK kinases. To determine if NCCRP-1 was physically associated with JAK2 kinase, chemical cross-linking experiments were conducted. NCC membrane preparations were treated with the chemical cross-linker DSS, solubilised and immunoprecipitated with anti-NCCRP-1 (e.g., 32 kDa) mab 5C6. WB analysis using anti-JAK2 mab and mab 5C6 demonstrated that the immunoprecipitate contained both the 32-kDa NCCRP-1 and 85-90-kDa JAK2 kinase. To examine further the possibility that STAT proteins may be associated with NCC/NCCRP-1 activation, NCC lysates were probed (WB) with various anti-STAT mabs. The strongest signal was produced by a 100-kDa STAT-6 protein. Lysates were negative for STAT-1, STAT-3 and STAT-5. These data indicate that the N-terminus of NCCRP-1 may initiate cytokine gene transcription by the JAK-STAT signalling pathway.

Apoptotic effect of outer-membrane proteins from Campylobacter jejuni on chicken lymphocytes

Campylobacter jejuni is a significant cause of food-borne diseases in humans. The bacterium is considered a commensal organism in chickens, and it can heavily colonize chickens without causing inflammation. Poultry may be the major reservoir for the human infection in developed countries. Here we show that an outer-membrane protein extract prepared from the bacteria caused apoptosis of chicken lymphocytes detected in vitro with the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay that preferentially labels individual apoptotic cells. Blood- and spleen-lymphocytes from different-aged chickens displayed a significantly greater percentage of apoptotic cells after culture with the outer-membrane proteins from C. jejuni than controls treated with phosphate-buffered saline, chicken ovalbumin, or outer-membrane proteins prepared from E. coli strain BL21. The C. jejuni extract also produced apoptosis of chicken lymphoblastoid tumor cell lines. Apoptosis was blocked by pretreating the extract with proteinase K or antiserum against outer-membrane proteins. The results suggest that C. jejuni may be capable of achieving immune avoidance in chickens by causing apoptosis of lymphocytes.

Depression in the medical setting: biopsychological interactions and treatment considerations

This article examines depression in 6 medical conditions: coronary artery disease (CAD), cancer, human immunodeficiency virus (HIV) infection, Parkinson's disease, pain, and the sex hormone changes of aging. Research is beginning to define specific biological and psychological mechanisms underlying the adverse interactions between depression and these medical conditions. Antidepressant medications, psychosocial therapies, and hormonal manipulations are effective in reducing depressive symptoms. Specific psychosocial interventions may increase longevity in CAD and cancer and may enhance quality of life in HIV infection. Newer antidepressants appear to be safer and better tolerated than older agents for medically ill patients, but do not appear to be as effective for neuropathic pain. Dopamine agonists may benefit depression associated with Parkinson's disease. Hormone replacement therapy may improve subsyndromal depressive symptoms in postmenopausal women and may enhance antidepressant response for older women with major depression.

Mechanisms of cellular cytotoxic innate resistance in tilapia (Oreochromis nilotica)

Mechanisms of innate cytotoxic immunity in tilapia (O. nilotica) were measured by characterization of the activity, distribution and functions of nonspecific cytotoxic cells (NCC). Active cytotoxic cells were obtained from anterior kidney. spleen and peripheral blood whereas nonlytic but anti-NCC monoclonal antibody 5C6 positive cells were obtained from tilapia liver. Thymocytes were not cytotoxic and were mab 5C6+. Unfractionated anterior kidney cells were 6% mab 5C6+ and had very low cytotoxicity of HL-60 target cells. Percoll (45.5%) purified NCC were 44% mab 5C6+ and had 35% HL-60 cytotoxicity (160:1 E:T ratio). Transformed mouse and human target cells were tested for sensitivity to NCC lysis. HL-60, U937, K562, IM-9 and NC-37 human targets were lysed by NCC. YAC-1 targets were insensitive to lysis. The killing of HL-60 targets by tilapia NCC was inhibited by mab 5C6. Experiments to determine optimal conditions for the cytotoxicity assay revealed that tilapia required 15-20h for optimum lysis of targets. Incubation at 37 C produced the highest cytotoxicity. The proliferative competence of Percoll purified anterior kidney cells was determined. A significant increase in in vitro uptake of tritiated thymidine by anterior kidney cells occurred following stimulation by mab 5C6, Con-A, PMA and calcium ionophore A23187. Purified spleen cells also produced significant increased uptake of tritiated thymidine following in vitro activation with PMA and mab 5C6, but not Con-A. These studies indicated that NCC may provide innate cytotoxic immunity similar to that provided by the NCC of catfish.

Skeletal muscle adaptations to prolonged training, overtraining and detraining in horses

Thirteen standard-bred horses were trained intensively for 34 weeks and detrained for 6 weeks to study skeletal muscle adaptations to prolonged training, overtraining and detraining. Training included endurance (phase 1, 7 weeks), high-intensity (phase 2, 9 weeks) and overload training (OLT) (phase 3, 18 weeks). During phase 3, horses were divided into two groups, OLT and control (C), with OLT horses performing greater intensities and durations of exercise than C horses. Overtraining was evident in OLT horses after week 31 and was defined as a significant reduction in treadmill run time in response to a standardised exercise test (P<0.05). Relationships between peripheral (skeletal muscle) and whole body (maximum O2 uptake, V.O2, max, treadmill run time) adaptations to training were determined. Prolonged training resulted in significant adaptations in morphological characteristics of skeletal muscle but the adaptations were limited and largely completed by 16 weeks of training. Fibre area increased in all fibres while the number of capillaries per fibre increased and the diffusional index (area per capillary) decreased. Mitochondrial volume density continued to increase throughout 34 weeks of training and paralleled increases in V.O2,max and treadmill run time. Significant correlations were noted between mitochondrial volume and V.O2,max (R=0.71), run time and V.O2,max (R=0.83) and mitochondrial volume and run time (R=0.57). We conclude that many of adaptive responses of muscle fibre area and capillarity occur in the initial training period but that markers of oxidative capacity of muscle indicate progressive increases in aerobic capacity with increases in training load. The lack of differences between C and OLT groups indicated that there may be an upper limit to the ability of training stimulus to evoke skeletal muscle adaptive responses. There was no effect of overtraining or detraining on any of the adaptive responses measured.

Special considerations: use of lithium in children, adolescents, and elderly populations

Certain populations of patients require special considerations when lithium is prescribed. Children and adolescents have higher volumes of body water and more active renal glomerular filtration rates than adults. Their central nervous system is developing and therefore is vulnerable to the impact of substances, including medications such as lithium, that can cause side effects or adverse events. Elderly patients have less body water, slower metabolism, and often comorbid illnesses, so they also require close evaluation and monitoring when prescribed lithium. This paper examines the indications for, pharmacokinetics of, clinical uses of, and side effects of lithium in children, adolescents, and the elderly. Use of alternate mood stabilizers is also addressed briefly.

Nonspecific cytotoxic cell receptor protein-1: a novel (predicted) type III membrane receptor on the teleost equivalent of natural killer cells recognizes conventional antigen

The phylogenetic model for "conventional" antigen recognition by NK cells may be a protein (NCCRP-1) recently identified from catfish nonspecific cytotoxic cells (NCC). NCCRP-1 may be a Type III membrane protein. The antigen binding domain was identified by competition experiments using synthetic peptides. Within this domain, a 38-mer peptide (aa 104-140) inhibited NCC killing of IM-9, HL-60, NC-37, U937, and MOLT-4 target cells. Biotinylated 38-mer also bound to IM-9 target cells. A mab which inhibited conjugate formation between NCC and target cells also bound to the 38-mer. Nonbiotinylated 38-mer inhibited mab 5C6 binding to immobilized homologous biotinylated peptide in cold competition ELISA experiments. Peptide 104-140 was truncated into two peptides. Amino acid 104-119 bound to (68%) and inhibited lyis of IM-9 target cells, whereas aa 120-140 had no activity. A predicted structure-function algorithm suggested an N-terminal domain containing BOX-1 motifs for cytokine activation; a C-terminal domain containing abundant phosphorylation sites (i.e., Y, S, and T amino acids); and an extracellular antigen binding domain.

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

This article reviews the burgeoning literature on the relationship of mood disorders and heart disease. Major depression and depressive symptoms, although commonly encountered in medical populations, are frequently underdiagnosed and undertreated in patients with cardiovascular disease (CVD). This is of particular importance because several studies have shown depression and its associated symptoms to be a major risk factor for both the development of CVD and death after an index myocardial infarction. This review of the extant literature is derived from MEDLINE searches (1966-1997) using the search terms "major depression," "psychiatry," "cardiovascular disease," and "pathophysiology." Studies investigating pathophysiological alterations related to CVD in depressed patients are reviewed. The few studies on treatment of depression in patients with CVD are also described. Treatment of depression in patients with CVD improves their dysphoria and other signs and symptoms of depression, improves quality of life, and perhaps even increases longevity. Recommendations for future research are proposed.

Psychiatric morbidity in endocrine disorders

Psychiatric disturbances are frequently observed during the course of endocrine disorders. This article discusses the history, current knowledge, assessment, and treatment of psychiatric morbidity in endocrine disorders. The primary focus is on biologic links between psychiatric symptoms and endocrine dysfunction. Psychiatric disorders associated with abnormalities of the pituitary, thyroid, parathyroids, adrenals, and gonads are discussed as well as the chronic illness of diabetes mellitus.

In vivo modulation of innate resistance to Edwardsiella ictaluri with a phosphatase inhibitor

Catfish were treated with the protein phosphatase inhibitor sodium orthovanadate (vanadate) and challenged with the pathogen Edwardsiella ictaluri to investigate the relationship between the in vivo immunoregulatory effects of tyrosine and serine phosphatases on nonspecific modulation of resistance to bacterial infections. Two different infection protocols were used: fish were pretreated by immersion in vanadate and subsequently infected (by immersion) with 1 LD100 E. ictaluri, or fish were injected (intraperitoneally, i.p.) with bacteria and simultaneously treated (by immersion) with 25 microM vanadate. In the absence of vanadate, both infection models produced fulminant infection by 10 or 6 d, respectively. Zero to 48 h treatment with vanadate (by immersion) prior to infection produced 17 to 100% survival of infected fish. In addition to augmentation of inmate immunity, vanadate enhanced acquired immunity to this pathogen. Fish which had vanadate-induced resistance to primary infection were 'immune' to secondary challenge with a LD100 of E. ictaluri. Experiments were done to determine the mechanism(s) of the altered innate resistance. Catfish were injected (i.p.) with E. ictaluri and simultaneously treated (by immersion) with 25 microM vanadate. Assays were done to measure nonspecific cytotoxic cell (NCC) activity at 0, 24, 48, 72 and 96 h post-infection/vanadate treatment. Increased NCC activity at 48 to 96 h post-infection appeared to correlate with resistance to bacterial related mortality. These data indicated that in vivo vanadate treatment of catfish significantly increased resistance to otherwise fulminant E. ictaluri infections. This effect coincided with the initiation of resistance to secondary infections without additional vanadate treatments. Vanadate-modulated resistance in catfish may be associated with augmented NCC activity.

Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I

The yeast Saccharomyces cerevisiae has been useful in establishing the phenotypic effects of specific mutations on the enzymatic activity and camptothecin sensitivity of yeast and human DNA topoisomerase I. To determine whether these phenotypes were faithfully reiterated in higher eukaryotic cells, wild-type and mutant yeast Top1 proteins were epitope-tagged at the amino terminus and transiently overexpressed in mammalian COS cells. Camptothecin preferentially induced apoptosis in cells expressing wild-type eScTop1p yet did not appreciably increase the cytotoxic response of cells expressing a catalytically inactive (eSctop1Y727F) or a catalytically active, camptothecin-resistant eSctop1vac mutant. Using an epitope-specific antibody, immobilized precipitates of eScTop1p were active in DNA relaxation assays, whereas immunoprecipitates of eScTop1Y727Fp were not. Thus, the enzyme retained catalytic activity while tethered to a support. Interestingly, the mutant eSctop1T722A, which mimics camptothecin-induced cytotoxicity in yeast through stabilization of the covalent enzyme-DNA intermediate, induced apoptosis in COS cells in the absence of camptothecin. This correlated with increased DNA cleavage in immunoprecipitates of eScTop1T722Ap, in the absence of the drug. The observation that the phenotypic consequences of expressing wild-type and mutant yeast enzymes were reiterated in mammalian cells suggests that the mechanisms underlying cellular responses to DNA topoisomerase I-mediated DNA damage are conserved between yeast and mammalian cells.

Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites

Plastic adherent interleukin-2-activated human natural killer (NK) cells (ALAK) lyse many different histological types of tumor target cells. In order to effect their function as cytotoxic mediators of innate immunity, ALAKs may 'recognize' antigen(s) of protozoan parasites, select virus-infected cells and they may release certain cytokines in response to bacterial antigens. In the present study, we demonstrate that CD3-/CD56dim/CD16dim/monoclonal antibody 5C6bright human ALAKs bind to an antigenic determinant on tumor cells independent of target cell H-2 allotype expression. The conserved antigen was originally obtained from the protozoan Tetrahymena pyriformis, however it is also located on the membranes of many ALAK-sensitive tumor cells. The sequence of this protein, i.e. NK target antigen/NKTag, was previously deduced from cDNA. One ALAK cognate determinant of NKTag was identified by inhibition of cytotoxicity using NKTag-derived synthetic peptides. Biotinylated synthetic peptide [amino acids (aa) 58-74] bound to ALAKs, and synthetic peptides corresponding to this sequence inhibited ALAK lysis of U937 target cells. Inhibition effects of peptide binding were nonreversible. To determine the requirements for recognition by ALAKs of this antigenic determinant, the cognate peptide aa 55-74 was truncated to 17-, 14-, 10-, 7- and 6-mer lengths and tested for inhibition of cytotoxicity. All inhibited except the 6-mer. A possible mechanism of peptide inhibition of cytotoxicity following ALAK binding to an antigenic determinant was a requirement for recognition of one anchor peptide (arginine) and receptor occupancy by a minimum of five to six additional amino acids. In antibody-dependent cell-mediated cytotoxicity experiments, synthetic peptide (aa 68-74) inhibited ALAK killing of anti-H-2d-sensitized P815 targets. This same peptide also inhibited conventional lysis of nonsensitized P815 and IM-9 targets. However, the cognate synthetic peptide (aa 58-74) did not inhibit conjugate formation between ALAKs and U937 target cells. These data demonstrate that ALAK binding to a soluble monomeric peptide inhibited cytotoxicity. Peptide binding appeared to negatively regulate cytotoxicity, and the inhibitory effects following peptide binding were nonreversible. Effector:target cell conjugate formation was not affected by peptide binding, however, recognition was required because inhibition was specific for the amino acid sequence of the synthetic peptide.

Evidence for antigen recognition by nonspecific cytotoxic cells: initiation of 3H-thymidine uptake following stimulation by a protozoan parasite and homologous cognate synthetic peptide

Catfish nonspecific cytotoxic cells bind to and lyse certain protozoan parasites and tumor cells. Target cell binding is facilitated by recognition of (minimally) one antigenic determinant. Binding to this determinant initiates multiple signalling pathways in NCC including protooncogene kinase phosphorylation, regulation of phosphatase activity and increased membrane receptor expression. In the present study, highly purified NCC were activated in vitro with the protozoan parasite Tetrahymena pyriformis, with a multiple antigenic peptide (MAP) composed of the cognate antigenic determinant of this parasite (i.e. natural killer target antigen/NKTag) and NCC were activated with a monoclonal antibody specific for the NCC receptor which binds NKTag. NCC were purified by Percoll density gradients and negative selection by panning (2x) over anti-sIg specific mab 9E1. In 5 day proliferation experiments, treatment of NCC with immobilized Tetrahymena initiated a significant increase in uptake of tritiated thymidine. This appeared to be a primary response in that NCC from in vivo parasite primed catfish did not have secondary-like proliferation responses. Stimulation of NCC with immobilized synthetic peptides composed of the cognate antigenic determinant of this parasite (i.e. MAP) also caused significant increased uptake of tritiated thymidine. An indication that NCC recognize a specific antigenic determinant was that sMAP (i.e. peptides composed of the same amino acids as MAP but in a scrambled sequence) failed to increase incorporation. Similar to the MAP results, mab 5C6 binding to NCC also caused increased thymidine uptake. To determine if an IL-2 cosignal was required to achieve optimum activation responses by NCC, different concentrations of human recombinant IL-2 (rHuIL-2) were tested individually or as costimulants. Co-treatment of NCC with rHuIL-2 and any of the three stimuli (parasite, MAP, mab 5C6) did not produce increased proliferation of NCC. These studies demonstrated that NCC specifically recognize an antigenic determinant on protozoan parasites and binding to this antigen produces an activation signal that may have important consequences for elicitation of innate immunity.

Receptor associated phosphorylation following monoclonal antibody or synthetic peptide binding to nonspecific cytotoxic cells

We have previously shown that crosslinkage of a receptor protein on catfish nonspecific cytotoxic cells (NCC) with anti-receptor monoclonal antibody or with a synthetic peptide activates cytotoxicity and initiates signalling responses. Receptor linked signalling was associated with the production of increased levels of expression of 50-60 and 20-30 kDa phosphoproteins determined by immunoprecipitation with anti-phosphoserine and anti-phosphotyrosine mabs. These proteins are components of a macromolecular protein complex (>200 kDa) determined by reducing and nonreducing SDS-PAGE. The calcium ionophore A23187 treatment produced the same pattern of phosphoprotein expression as peptide or mab. Maximum phosphoserine expression occurred at 15'-30' post-mab binding. We now show that synthetic peptide or mab treatment initiated the same serine and tyrosine phosphorylation profiles. The PKC specific inhibitor MDL 29,152 produced 50% inhibition of NCC lysis of IM-9 target cells, and completely inhibited serine phosphorylation of peptide activated cells but had no effect on tyrosine phosphorylation of the phosphointermediates. Genistein pretreatment of NCC inhibited cytotoxicity and tyrosine phosphorylation. Sequential immunprecipitation of the phosphointermediate demonstrated that the phosphorylated serine and tyrosine residues were on the same 50-60 kDa protein. These data indicate that both proximal and distal signalling events required for NCC activation may be associated with ATPase phosphorylation.

Housing and exercise of dogs: effects on behavior, immune function, and cortisol concentration

We examined the effect of supplemental exercise (either individually or with a conspecific) on the physical and psychological health of dogs by measuring immune, endocrine, and behavioral responses. Forty purpose-bred adult male beagles were assigned to one of four treatment conditions: exercised individually (EI), exercised with a conspecific (EC), nonexercised (NE), or cage control (CC). Each EI dog was removed from its cage, carried to an empty room, and allowed to exercise alone for 20 min/d 3 days a weeks for 12 weeks. Two EC dogs were allowed to exercise together following a similar schedule. To control for potential handling effects, NE dogs were removed from their cages, carried to the exercise room, but immediately returned to their cages, and CC dogs remained in their cages during scheduled exercise periods. Detailed behavioral observations, humoral immune responses to the antigen keyhole-limpet hemocyanin, peripheral blood mononuclear cell subsets, plasma cortisol concentration, body weight, and total and differential white blood cell (WBC) counts were routinely monitored. Results indicated few significant treatment effects on physiologic or behavioral measures. Specifically, EC dogs had lower percentages of B lymphocytes, and EC and EI dogs barked more than did NE or CC dogs. However, some physiologic and behavioral measures changed as a function of time regardless of treatment condition. Most notably, for all dogs over time, WBC counts, plasma cortisol values, and behavioral measures reflecting inactivity decreased, while measures reflecting high activity and abnormal behaviors increased. We concluded that neither exercise treatment substantially altered the physical health of research dogs, and perhaps more importantly, failed to prevent the development of abnormal behavior.